Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma of Lung × tislelizumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Esophageal Squamous Cell Carcinoma 4 Carcinoma, Hepatocellular 4 Advanced Solid Tumors 4 Recurrence 3 Neoplasm Metastasis 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Solid Tumors 1 Sarcoma 1 Neuroendocrine Tumors 1 Nasopharyngeal Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Locally Advanced or Metastatic Urothelial Bladder Cancer 1 Locally Advanced and Metastatic Solid Tumors 1 Limited Stage Small Cell Lung Cancer 1

Interventions

Carboplatin 22 Bevacizumab 17 Paclitaxel 16 Pemetrexed 14 Radiotherapy 11 Erlotinib Hydrochloride 11 Docetaxel 7 Gemcitabine 5 Cetuximab 5 ceritinib 4 Taxes 4 Cisplatin 4 pembrolizumab 3 Surgical Procedures, Operative 3 Radiosurgery 3 Metformin 3 Gefitinib 3 Cyclophosphamide 3 pegfilgrastim 2 capmatinib 2 Thalidomide 2 Sorafenib 2 Radiotherapy, Conformal 2 Nivolumab 2 Immunoglobulin G 2 Filgrastim 2 Disulfides 2 Albumin-Bound Paclitaxel 2 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 2 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡